KLOW
at the molecular level.
Gut, skin, recovery.
One combined vial.
KPV · GHK-Cu · BPC-157 · TB-500 · single vial
Gut, skin, recovery.
One combined vial.
KLOW adds KPV — the C-terminal tripeptide of α-MSH studied for its role in inflammatory signalling — to the GLOW base of GHK-Cu, BPC-157 and TB-500, combined in a single lyophilised vial. The four-compound blend is referenced in research spanning mucosal, dermal and soft-tissue repair endpoints from one reconstitution.
Subcutaneous lyophilised formulation. Pharmacokinetic parameters validated by HPLC-MS at our Swiss reference lab.
Every BIOHACKER batch ships with a third-party HPLC-MS certificate signed by the Swiss reference lab.
No verified reviews yet. Verified buyers can review the documentation, purity, and handling below.
Sign in to leave a verified review of a product you’ve purchased.